231 filings
Page 2 of 12
8-K
bm2yf9v hvl
31 Jul 23
ABVC BioPharma Announces Closing on $1.75 Million Registered Direct Offering
9:30am
8-K
sue9biecimsgob
27 Jul 23
Entry into a Material Definitive Agreement
9:14am
8-K
hfho7p8m0
24 Jul 23
ABVC BioPharma Announces Reverse Stock Split
9:02am
8-K
hb87 utmgo
7 Jul 23
Submission of Matters to a Vote of Security Holders
5:00pm
8-K
iyp0kis
23 Jun 23
Departure of Directors or Certain Officers
4:01pm
8-K
c6219g8k
15 Jun 23
Departure of Directors or Certain Officers
5:00pm
8-K
ie4m0ecevr3 on3
9 Jun 23
Regulation FD Disclosure
5:00pm
8-K
pwssm7toh ut2ir
9 Jun 23
Other Events
5:00pm
8-K
yds9q9zt01wz
26 May 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:31pm
8-K
tnbgsuz6
24 Apr 23
Submission of Matters to a Vote of Security Holders
2:56pm
8-K
y1pp546x
31 Mar 23
ABVC BioPharma Announces Fiscal Year 2022 Financial and Operational Results
4:47pm
8-K
gfe3 k5b9
24 Feb 23
ABVC BioPharma Receives $3.175 Million Investment from The Lind Partners to Continue Clinical Trials
4:30pm
8-K
xzogxxoj mii
16 Feb 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:30pm
8-K
3e5k ltjmyn2uwdch
21 Oct 22
Changes in Registrant's Certifying Accountant
4:30pm
8-K
7e4ljr o293fy40
13 Sep 22
ABVC Biopharma Announces Letter to Shareholders
10:47am
8-K
m38 h00vx820
9 Sep 22
Departure of Directors or Certain Officers
4:30pm
8-K
xvlqlo
22 Aug 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:30pm
8-K
ne90kq
14 Jul 22
Departure of Directors or Certain Officers
5:00pm
8-K
q8kzz7
21 Jun 22
ABVC BioPharma Expands Co-Development Partnership with Rgene Corporation
2:07pm
8-K
kdpipo1
1 Jun 22
Departure of Directors or Certain Officers
6:10am